Quantcast

Latest leukemia Stories

2014-09-12 23:05:19

North Texas Indoor Trampoline Park to Help Raise Money During the 2014-2015 School Year Frisco, Texas (PRWEB) September 12, 2014 Leukemia, the most common cancer in children under the age of 20 years old, affects about 4,103 school aged children every year in the US alone. For youth and their families, the diagnosis can be both mentally and financially crushing. In an effort to decrease these hardships and incentivize students to raise money for the cause, Urban Air Trampoline Park is...

2014-09-11 23:05:47

September is Blood Cancer Awareness Month, making it the perfect time to announce next year’s law school scholarship for survivors or family members affected by blood cancers. San Diego, California (PRWEB) September 11, 2014 September is Blood Cancer Awareness Month, a national event to bring much needed attention to these disorders. That makes September the perfect time to announce next year’s law school scholarship for survivors or family members affected by blood cancers. The Law...

2014-09-10 23:02:03

Lab Testing Company Encourages Bone Marrow Donation Participation Alpharetta, Ga. (PRWEB) September 10, 2014 September is Blood Cancer Awareness Month, observed by The Leukemia & Lymphoma Society as a means to raise awareness of blood cancers and efforts implemented to provide research and treatment. ANY LAB TEST NOW®, who has partnered with Delete Blood Cancer, is celebrating at select locations by encouraging customers to become donors by hosting swab parties, collecting...

2014-09-10 16:25:08

Stage set to determine if drugs called tyrosine kinase inhibitors will extend the lives of patients with the high-risk acute lymphoblastic leukemia subtype; pediatric clinical trial scheduled to open by early 2015 MEMPHIS, Tenn., Sept. 10, 2014 /PRNewswire-USNewswire/ -- More than one-quarter of young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and may benefit from drugs widely used to treat other types of...

2014-09-10 12:24:59

Thousands to Walk to Raise Funds for Blood Cancer Research SAN FRANCISCO, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Northern California Chapter will be kicking off its 2014 Light The Night(®) Walk campaign with the San Francisco Walk on September 23, 2014 at 5 p.m. PT at AT&T Park. The Light The Night Walk is a powerful and unique fundraising campaign from LLS, which brings together families and communities to honor blood cancer...

2014-09-10 12:24:45

Behind The Bench, The National Basketball Wives Association and The Leukemia & Lymphoma Society Team up for Cancer Cures WHITE PLAINS, N.Y., Sept. 10, 2014 /PRNewswire-USNewswire/ -- 11-year-old Kyle Markes passed away of acute lymphoblastic leukemia (ALL) on December 24, 2013, just days before he was set to be his idol Kevin Durant's special guest at an Oklahoma Thunder game on Christmas Day. Every three minutes, someone in the U.S. is diagnosed with a blood cancer. Almost 150,000...

2014-09-09 16:25:53

WHITE PLAINS, N.Y., Sept. 9, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) announced today that Louis J. DeGennaro, Ph.D., has been appointed as president and chief executive officer, effective immediately. http://photos.prnewswire.com/prnvar/20140909/144436 "Dr. DeGennaro has tirelessly dedicated himself for almost a decade of service to the LLS mission and to the patients whom we all serve, and this appointment is in recognition of his vision,...

2014-09-09 08:32:43

SAN DIEGO, Sept. 9, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced results for its fiscal year ended June 30, 2014. "I am very proud of all that we have accomplished over the past year, highlighted by significant progress toward the clinical development of our lead drug candidate Pracinostat," said Daniel P. Gold, Ph.D., President and Chief Executive Officer of MEI Pharma. "Now we...

2014-09-08 16:25:31

The Encore at Wynn Las Vegas: September 11th, 2014 ZUG, Switzerland and NEW YORK, Sept. 8, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company that acquires and develops innovative products for the treatment of various indications in cancer and the central nervous system (CNS), including orphan indications, today announced that Dr. Angelos M. Stergiou, Chief Executive Officer and Chairman of the Board of SELLAS, will...

2014-09-08 08:29:38

SAN DIEGO and TORONTO, Sept. 8, 2014 /PRNewswire/ - Aptose Biosciences Inc. (TSX: APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced that Stephen B. Howell, M.D. will act in the capacity of Chief Medical Officer. Dr. Howell joins the Aptose team as a medical consultant to provide expert clinical guidance to the company. "Dr. Howell brings to Aptose deep industry and academic...


Latest leukemia Reference Libraries

Clinical Leukemia
2012-05-18 15:34:28

Clinical Leukemia is a peer-reviewed medical journal published by CIG Media Group. The journal publishes articles on detection, diagnosis, prevention, and treatment of leukemia. The main emphasis is on recent scientific developments in all areas related to leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance, gene and antisense therapy; pathology, markers, and prognostic indicators, chemoprevention strategies,...

More Articles (1 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related